☆ 4.2 Article

Cerebral embolic protection systems for transcatheter aortic valve replacement

JOURNAL OF INTERVENTIONAL CARDIOLOGY (2018)

Journal

JOURNAL OF INTERVENTIONAL CARDIOLOGY

Volume 31, Issue 6, Pages 891-898

Publisher

WILEY

DOI: 10.1111/joic.12573

Keywords

cerebral embolic protection; cerebral protection devices; stroke; TAVI; TAVR

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

In the recent years, ischemic brain injury related to embolization after transcatheter aortic valve replacement (TAVR) has received increased attention as new embolic protection strategies emerged to protect the brain. Diverse cerebral protection devices have been developed to reduce cerebral embolization during TAVR. These devices work through various mechanisms and are in different stages of clinical translation. This review provides the evidence-based review of peri-procedural stroke prevention during TAVR and summarizes currently available cerebral embolic protection devices.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Heterogeneity of debris captured by cerebral embolic protection filters during TAVI

Herbert Kroon, Jan H. von der Thusen, Francesca Ziviello, Maarten van Wiechen, Joris F. W. Ooms, Isabella Kardys, Marguerite Schipper, Lennart van Gils, Joost Daemen, Peter de Jaegere, Nicolas M. Van Mieghem

Summary: This study aimed to investigate the debris captured during transcatheter valve implantation, with findings showing differences in debris composition among different valve types. The Lotus valve was associated with a higher frequency of capturing foreign body materials, endothelium, calcified material, and myocardial tissue compared to other valve types. Repositioning of the valve and certain valve types were found to be risk factors for dislodging larger particles to the brain.

EUROINTERVENTION (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Stroke prevention during and after transcatheter aortic valve implantation: From cerebral protection devices to antithrombotic management

Victor Alfonso Jimenez Diaz, Rodrigo Estevez Loureiro, Jose Antonio Baz Alonso, Pablo Juan Salvadores, Guillermo Bastos Fernandez, Berenice Caneiro Queija, Cesar Veiga Garcia, Andres Iniguez Romo

Summary: Transcatheter aortic valve implantation (TAVI) has been widely adopted as a therapeutic approach for severe symptomatic aortic stenosis. However, thromboembolic and hemorrhagic complications remain a concern. This review discusses the etiology, incidence, prevention strategies, and pharmacological management of these complications in TAVI patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Factors associated with a high or low implantation of self-expanding devices in TAVR

Verena Veulemans, Oliver Maier, Kerstin Piayda, Kira Lisanne Berning, Stephan Binneboessel, Amin Polzin, Shazia Afzal, Lisa Dannenberg, Patrick Horn, Christian Jung, Ralf Westenfeld, Malte Kelm, Tobias Zeus

Summary: The study found that rapid ventricular pacing (RP) can achieve the highest implantation depth, while left ventricular outflow calcification, a flare aortic root, and RP are independent predictors of deep implantation depth. The number of protective criteria is significantly related to the depth of implantation.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement

Daniela Geisler, Piotr Nikodem Rudzinski, Waseem Hasan, Martin Andreas, Ena Hasimbegovic, Christopher Adlbrecht, Bernhard Winkler, Gabriel Weiss, Andreas Strouhal, Georg Delle-Karth, Martin Grabenwoeger, Markus Mach

Summary: The study identified risk factors associated with higher one-year mortality following TF and TA TAVR, including cerebrovascular disease, home oxygen dependency, wheelchair dependency, periinterventional myocardial infarction, and postinterventional renal replacement therapy. It emphasizes the importance of precise preinterventional evaluation and highlights the subtle differences in baseline characteristics between the TF and TA cohorts and their impact on one-year mortality.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Case report of snaring-assisted TAVR under cerebral embolic protection: the Chaperone with Top Hat technique

Massimo Medda, Francesco Casilli, Marta Bande, Maurizio Tespili, Francesco Donatelli

Summary: This case report describes a patient with severe aortic stenosis who underwent TAVR with complete cerebral protection using Triguard system device and "snaring-assisted" valve advancement.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Use and Outcomes of Cerebral Protection Devices for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Clinical Practice

Peter Stachon, Klaus Kaier, Timo Heidt, Dennis Wolf, Daniel Duerschmied, Dawid Staudacher, Manfred Zehender, Christoph Bode, Constantin von zur Muehlen

Summary: This study analyzed TAVR procedures in Germany and found that cerebral protection devices were infrequently used. While the use of these devices was associated with lower in-hospital mortality, it did not reduce the risk of stroke or delirium. Future studies are needed to confirm these findings.

JACC-CARDIOVASCULAR INTERVENTIONS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Incidence, clinical impact and predictors of thrombocytopenia after transcatheter aortic valve replacement

Gabriela Tirado-Conte, Carlos H. Salazar, Angela McInerney, Alejandro Cruz-Utrilla, Pilar Jimenez-Quevedo, Javier Cobiella, Nieves Gonzalo, Manuel Carnero, Pablo Salinas, Fernando Macaya, Luis C. Maroto, Isidre Vilacosta, Antonio Fernandez-Ortiz, Javier Escaned, Carlos Macaya, Luis Nombela-Franco

Summary: Thrombocytopenia is a common complication after TAVR, and its severity can predict clinical outcomes. This study found that a decrease in platelet count of more than 46% and a late nadir were associated with early mortality and higher two-year mortality. These findings highlight the importance of monitoring platelet levels in TAVR patients and may help guide treatment decisions.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial

Dariusz Jagielak, Radoslaw Targonski, Christian Frerker, Mohamed Abdel-Wahab, Johannes Wilde, Nikos Werner, Michael Lauterbach, Juergen Leick, Marek Grygier, Marcin Misterski, Andrejs Erglis, Inga Narbute, Adam Ryszard Witkowski, Matti Adam, Derk Frank, Fernando Gatto, Tobias Schmidt, Alexandra J. Lansky

Summary: The PROTEMBO C Trial evaluated the safety and performance of the ProtEmbo Cerebral Protection System in TAVI patients. The results showed that the ProtEmbo device achieved the expected safety and performance endpoints in TAVI surgeries, reducing brain lesion volume.

EUROINTERVENTION (2022)

Add to Collection

Article Medicine, General & Internal

A Referral Center Experience with Cerebral Protection Devices: Challenging Cardiac Thrombus in the EP Lab

Jan Berg, Alberto Preda, Nicolai Fierro, Alessandra Marzi, Andrea Radinovic, Paolo Della Bella, Patrizio Mazzone

Summary: This study examined the feasibility and safety of using cerebral protection devices in high-risk patients with cardiac thrombus undergoing cardiac procedures in the electrophysiology lab. The results showed that the use of these devices was feasible and safe, with no occurrence of cerebral thromboembolic events, but there were potential vascular complications. Further larger and randomized trials are needed to confirm these findings.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device

Mathias Wolfrum, Immanuel Justus Handerer, Federico Moccetti, Alexander Schmeisser, Ruediger C. Braun-Dullaeus, Stefan Toggweiler

Summary: This study provides evidence that the use of Sentinel CEP during TAVR is effective in reducing the risk of stroke and disabling stroke. It also demonstrates a lower risk of major or life-threatening bleeding associated with the use of Sentinel CEP.

BMC CARDIOVASCULAR DISORDERS (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement REFLECT II

Tamim M. Nazif, Jeffrey Moses, Rahul Sharma, Abhijeet Dhoble, Joshua Rovin, David Brown, Philip Horwitz, Rajendra Makkar, Robert Stoler, John Forrest, Steven Messe, Sarah Dickerman, Joseph Brennan, Robert Zivadinov, Michael G. Dwyer, Alexandra J. Lansky

Summary: The REFLECT II trial demonstrated that the TG3 was safe compared with a historical PG but did not meet its pre-specified primary superiority efficacy endpoint.

JACC-CARDIOVASCULAR INTERVENTIONS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial

Rajesh K. Kharbanda, Alexander D. Perkins, James Kennedy, Adrian Banning, Andreas Baumbach, Daniel J. Blackman, Matthew Dodd, Richard Evans, David Hildick-Smith, Zahra Jamal, Peter Ludman, Stephen Palmer, Rodney Stables, Tim Clayton

Summary: The BHF PROTECT-TAVI trial aims to provide definitive evidence on the clinical efficacy and cost-effectiveness of using routine cerebral embolic protection (CEP) with the SENTINEL device to reduce stroke in patients undergoing transcatheter aortic valve implantation (TAVI). The trial has enrolled 3,068 patients out of the total target of 7,730, and the primary outcome is the incidence of stroke at 72 hours post-TAVI.

EUROINTERVENTION (2023)

Add to Collection

Article Health Care Sciences & Services

Cerebral Protection in TAVR-Can We Do Without? A Real-World All-Comer Intention-to-Treat Study-Impact on Stroke Rate, Length of Hospital Stay, and Twelve-Month Mortality

Carolina Dona, Matthias Koschutnik, Christian Nitsche, Max-Paul Winter, Veronika Seidl, Jolanta Siller-Matula, Markus Mach, Martin Andreas, Philipp Bartko, Andreas Anselm Kammerlander, Georg Goliasch, Irene Lang, Christian Hengstenberg, Julia Mascherbauer

Summary: This study aimed to explore the impact of Sentinel (TM) on patients undergoing TAVR. The results showed that patients who received Sentinel (TM) had lower rates of stroke, shorter length of hospital stay, and improved 12-month survival. These findings support the use of Sentinel (TM) when implanting TAVR valves.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cerebral embolic protection during transcatheter heart interventions

Victor Alfonso Jimenez Diaz, Samir R. Kapadia, Axel Linke, Darren Mylotte, Alexandra Lansky, Eberhard Grube, Magnus Settergren, Rishi Puri

Summary: Stroke is a serious complication of transcatheter aortic valve replacement (TAVR), with a fixed incidence of about 3%. Cerebral embolic protection devices (CEPD) can reduce the volume of new cerebral lesions, but the evidence for these devices is limited. Furthermore, the use of CEPD in non-TAVR transcatheter heart interventions is an emerging area of study.

EUROINTERVENTION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Carotid ultrasound following transcarotid transcatheter aortic valve replacement

Vassili Panagides, Dimitri Kalavrouziotis, Eric Dumont, Robert Delarochelliere, Jean-Michel Paradis, Jules Mesnier, Siamak Mohammadi, Josep Rodes-Cabau

Summary: This study evaluated the safety of transcatheter aortic valve replacement (TAVR) via the transcarotid route through pre- and post-procedure carotid artery ultrasound assessment. The results showed that TC-TAVR was associated with a mild but significant increase in carotid flow velocities, without clinical events. Further studies are needed.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

Suleman Aktaa, Gorav Batra, Stefan K. James, Daniel J. Blackman, Peter F. Ludman, Mamas A. Mamas, Mohamed Abdel-Wahab, Gianni D. Angelini, Martin Czerny, Victoria Delgado, Giuseppe De Luca, Agricola Eustachio, Dan Foldager, Christian W. Hamm, Bernard Iung, Norman Mangner, Julinda Mehilli, Gavin J. Murphy, Darren Mylotte, Radoslaw Parma, Anna Sonia Petronio, Bodgan A. Popescu, Lars Sondergaard, Rui C. Teles, Manel Sabate, Christian J. Terkelsen, Luca Testa, Jianhua Wu, Aldo P. Maggioni, Lars Wallentin, Barbara Casadei, Chris P. Gale

Summary: The EuroHeart project aims to create pan-European data standards for cardiovascular diseases and interventions, including TAVI, to quantify quality of care and patient outcomes.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Add to Collection

Article Immunology

Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

Norman Mangner, Vassili Panagides, David del Val, Mohamed Abdel-Wahab, Lisa Crusius, Eric Durand, Nikolaj Ihlemann, Marina Urena, Costanza Pellegrini, Francesco Giannini, Tomasz Gasior, Wojtek Wojakowski, Martin Landt, Vincent Auffret, Jan-Malte Sinning, Asim N. Cheema, Luis Nombela-Franco, Chekrallah Chamandi, Francisco Campelo-Parada, Erika Munoz-Garcia, Howard C. Herrmann, Luca Testa, Won-Keun Kim, Helene Eltchaninoff, Lars Sondergaard, Dominique Himbert, Oliver Husser, Azeem Latib, Herve Le Breton, Clement Servoz, Philippe Gervais, Melanie Cote, Holger Thiele, David Holzhey, Axel Linke, Josep Rodes-Cabau

Summary: In transcatheter aortic valve related infective endocarditis (IE), absent echocardiographic signs of IE were associated with the same prognosis as evident echocardiographic signs, highlighting the need for early treatment initiation in high-risk patients presenting with positive blood cultures and symptoms of infection after TAVI.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy

Benedikt Schrage, Jonas Sundermeyer, Stefan Blankenberg, Pascal Colson, Dennis Eckner, Matthias Eden, Ingo Eitel, Derk Frank, Norbert Frey, Tobias Graf, Paulus Kirchhof, Danny Kupka, Ulf Landmesser, Axel Linke, Nicolas Majunke, Norman Mangner, Octavian Maniuc, Johannes Mierke, Sven Moebius-Winkler, David A. Morrow, Marc Mourad, Peter Nordbeck, Martin Orban, Federico Pappalardo, Sandeep M. Patel, Matthias Pauschinger, Vittorio Pazzanese, Darko Radakovic, P. Christian Schulze, Clemens Scherer, Robert H. G. Schwinger, Carsten Skurk, Holger Thiele, Anubodh Varshney, Lukas Wechsler, Dirk Westermann

Summary: This study evaluates the association between timing of active left ventricular (LV) unloading and implantation of VA-ECMO with outcomes in patients with cardiogenic shock (CS). The results show that early active LV unloading is associated with a lower risk of 30-day mortality and a higher likelihood of successful weaning from ventilation, without increasing complications.

JACC-HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock

Benedikt Schrage, Jonas Sundermeyer, Benedikt Norbert Beer, Letizia Bertoldi, Alexander Bernhardt, Stefan Blankenberg, Jeroen Dauw, Zouhir Dindane, Dennis Eckner, Ingo Eitel, Tobias Graf, Patrick Horn, Paulus Kirchhof, Stefan Kluge, Axel Linke, Ulf Landmesser, Peter Luedike, Enzo Luesebrink, Norman Mangner, Octavian Maniuc, Sven Moebius Winkler, Peter Nordbeck, Martin Orban, Federico Pappalardo, Matthias Pauschinger, Michal Pazdernik, Alastair Proudfoot, Matthew Kelham, Tienush Rassaf, Hermann Reichenspurner, Clemens Scherer, Paul Christian Schulze, Robert H. G. Schwinger, Carsten Skurk, Marek Sramko, Guido Tavazzi, Holger Thiele, Luca Villanova, Nuccia Morici, Antonia Wechsler, Ralf Westenfeld, Ephraim Winzer, Dirk Westermann

Summary: This study aimed to evaluate the use of mechanical circulatory support (MCS) for the treatment of non-ischaemic cardiogenic shock (CS). The results showed that the use of MCS was associated with a lower 30-day mortality rate in patients with non-ischaemic CS. However, MCS treatment was also associated with more complications.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Add to Collection

Article Medicine, General & Internal

Impact of Enterococci vs. Staphylococci Induced Infective Endocarditis after Transcatheter Aortic Valve Implantation

Tomasz Gasior, Felix J. Woitek, Antonia Schroth, Mohamed Abdel-Wahab, Lisa Crusius, Stephan Haussig, Philipp Kiefer, Piotr Scislo, Zenon Huczek, Maciej Dabrowski, Adam Witkowski, Anna Olasinska-Wisniewska, Marek Grygier, Marcin Protasiewicz, Damian Hudziak, Utz Kappert, David Holzhey, Wojtek Wojakowski, Axel Linke, Norman Mangner

Summary: This study compared the clinical characteristics and outcomes of patients with enterococci infective endocarditis (EC-IE) and staphylococci infective endocarditis (SC-IE) following transcatheter aortic valve implantation. The results showed that EC-IE was associated with lower morbidity and mortality compared to SC-IE.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction

B. E. Stahli, F. Varbella, A. Linke, B. Schwarz, S. B. Felix, M. Seiffert, R. Kesterke, P. Nordbeck, B. Witzenbichler, I. M. Lang, M. Kessler, C. Valina, A. Dibra, M. Rohla, M. Moccetti, M. Vercellino, L. Gaede, L. Bott-Flugel, P. Jakob, J. Stehli, A. Candreva, C. Templin, M. Schindler, M. Wischnewsky, G. Zanda, G. Quadri, N. Mangner, A. Toma, G. Magnani, P. Clemmensen, T. F. Luscher, T. Munzel, P. C. Schulze, K. -L. Laugwitz, W. Rottbauer, K. Huber, F. -J. Neumann, S. Schneider, F. Weidinger, S. Achenbach, G. Richardt, A. Kastrati, I. Ford, W. Maier, F. Ruschitzka

Summary: This study investigated the timing of complete revascularization in patients with STEMI and multivessel coronary artery disease. The findings suggest that immediate multivessel PCI is as effective as staged PCI.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF

Norman Mangner, Ephraim B. Winzer, Axel Linke, Volker Adams

Summary: This review provides a contemporary summary of the clinical and molecular alterations in the skeletal muscles of heart failure patients, with a focus on the effects on locomotor and respiratory muscles, particularly the diaphragm. It also discusses current and future therapeutic options, mainly focusing on the effects of exercise training.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Add to Collection

Correction Cardiac & Cardiovascular Systems

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) (October, qcac063, 2022)

Suleman Aktaa, Gorav Batra, Stefan K. James, Daniel J. Blackman, Peter F. Ludman, Mamas A. Mamas, Mohamed Abdel-Waha, Gianni D. Angelini, Martin Czerny, Victoria Delgado, Giuseppe De Luca, Eustachio Agricola, Dan Foldage, Christian W. Hamm, Bernard Iung, Norman Mangner, Julinda Mehilli, Gavin J. Murphy, Darren Mylotte, Radoslaw Parma, Anna Sonia Petronio, Bodgan A. Popescu, Lars Sondergaard, Rui C. Teles, Manel Sabate, Christian J. Terkelsen, Luca Testa, Jianhua Wu, Aldo P. Maggioni, Lars Wallentin, Barbara Casade, Chris P. Gale

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

VARC-3 defined outcome of valve-in-valve transcatheter aortic valve implantation in stentless compared with stented aortic bioprostheses

Jean-Honore Steul, Mohamed Abdel-Wahab, Tomasz Stankowski, Stephan Haussig, Felix J. Woitek, Tomasz Gasior, Lisa Crusius, Luise Knorr, Felicitas V. Mueller, Dirk Fritzsche, Philipp Kiefer, Utz Kappert, David Holzhey, Axel Linke, Norman Mangner

Summary: This study compared the outcomes of ViV-TAVI in patients with stentless and stented aortic bioprosthetic valve failure. The study found that both groups had comparable technical success, device success, and early safety. There were no significant differences in 30-day and 5-year mortality rates between the two groups.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Add to Collection

Meeting Abstract Cardiac & Cardiovascular Systems

Clinical presentation, shock severity and mortality in patients with de novo vs. acute-on-chronic heart failure-related cardiogenic shock

J. Jonas Sundermeyer, F. Gustafsson, C. Kellner, B. N. Beer, S. Blankenberg, P. Kirchhof, P. Luedike, N. Mangner, P. Nordbeck, M. Orban, A. Proudfoot, G. Tavazzi, H. Thiele, D. Westermann, B. Schrage

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial

Javed Butler, Muhammad Shahzeb Khan, Tomasz Gasior, Tyler R. Erickson, Vanja Vlajnic, Frank Kramer, Robert O. Blaustein, David Goldsbury, Lothar Roessig, Carolyn S. P. Lam, Kevin J. Anstrom, Paul W. Armstrong

Summary: This study found that accelerometer-based activity measures did not correlate with subjective or objective standard measures of health status and functional capacity in heart failure with preserved ejection fraction.

ESC HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation

Norman Mangner, Miriam Brinkert, Lukas S. Keller, Noriaki Moriyama, Daniel Hagemeyer, Stephan Haussig, Lisa Crusius, Richard Kobza, Mohamed Abdel-Wahab, Mika Laine, Stefan Stortecky, Thomas Pilgrim, Fabian Nietlispach, Frank Ruschitzka, Holger Thiele, Stefan Toggweiler, Axel Linke

Summary: This study aimed to investigate the safety and effectiveness of continued non-vitamin K antagonist oral anticoagulant (NOAC) therapy compared with continued vitamin K antagonist (VKA) therapy during transcatheter aortic valve implantation (TAVI). The study found that continued NOAC therapy led to comparable outcomes to continued VKA therapy, suggesting that both drugs can be used for long-term oral anticoagulation in TAVI patients.

EUROINTERVENTION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry

Mohamed Abdel-Wahab, Ines Richter, Maurizio Taramasso, Axel Unbehaun, Tanja K. Rudolph, Flavio Ribichini, Ronald Binder, Joachim Schofer, Norman Mangner, Jan-Henk Dambrink, Blanca Trejo-Velasco, Holger Thiele, Mitsunobu Kitamura, Jonas Lanz

Summary: This study evaluated the procedural and one-year outcomes of the BASILICA technique in high-risk patients undergoing TAVI. The results showed that BASILICA was feasible and effective in preventing TAVI-induced CAO, and the one-year clinical outcomes were favorable.

EUROINTERVENTION (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.